FDA drug class
Sphingosine 1-phosphate Receptor Modulators list
Every FDA-approved prescription drug the FDA NDC directory tags with the Sphingosine 1-phosphate Receptor Modulator [EPC] class, with brand names and DEA schedules.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
The FDA NDC directory lists 6 single-ingredient drugs in this class: etrasimod, fingolimod, fingolimod lauryl, ozanimod, ponesimod, siponimod.
Run it in Rivvi
Map Velsipity and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Sphingosine 1-phosphate Receptor Modulators (6)
| Drug | Brand names | Type | NDC listings | DEA schedule |
|---|---|---|---|---|
| Etrasimod | Velsipity | Single ingredient | 1 | Not controlled |
| Fingolimod | Gilenya | Single ingredient | 23 | Not controlled |
| Fingolimod lauryl | Tascenso ODT | Single ingredient | 2 | Not controlled |
| Ozanimod | Zeposia | Single ingredient | 1 | Not controlled |
| Ponesimod | Ponvory | Single ingredient | 2 | Not controlled |
| Siponimod | Mayzent | Single ingredient | 3 | Not controlled |
FDA established pharmacologic class: Sphingosine 1-phosphate Receptor Modulator [EPC].
Questions
What drugs are Sphingosine 1-phosphate Receptor Modulators?
The FDA NDC directory lists 6 single-ingredient drugs in this class: etrasimod, fingolimod, fingolimod lauryl, ozanimod, ponesimod, siponimod.
Where does this list come from?
From the established pharmacologic class (EPC) field FDA publishes for each listing in the NDC directory. A drug is listed when most of its prescription listings carry the class.